University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis, Carcinoma, Non-Small-Cell Lung.
Sponsors: Janssen Research & Development, LLC, Janssen Scientific Affairs, LLC.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine has 5 clinical trials on record, with 4 currently active. Their work covers Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis, Carcinoma, Non-Small-Cell Lung.
University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.